SPAG9 anticorps (N-Term)
Aperçu rapide pour SPAG9 anticorps (N-Term) (ABIN2293505)
Antigène
Voir toutes SPAG9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- JLP, NT (JNK-associated Leucine-zipper Protein, Cancer/testis Antigen 89, CT89, HSS, Human Lung Cancer Oncogene 6 Protein, HLC6, HLC-6, c-Jun-amino-terminal Kinase-interacting Protein 4, JNK-interacting Protein 4, JIP4, JIP-4, KIAA0516, Mitogen-activated Protein Kinase 8-interacting Protein 4, MAPK8IP4, Proliferation-inducing Protein 6, PIG6, Protein Highly Expressed in Testis, PHET, Sperm Associated Antigen 9, SPAG9, Sperm-specific Protein, Sperm Surface Protein, Sunday Driver 1, SYD1)
-
Purification
- Purified by ammonium sulfate precipitation.
-
Immunogène
- Synthetic peptide selected from the N-terminal region of human SPAG9 (KLH).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- SPAG9 (Sperm Associated Antigen 9 (SPAG9))
-
Autre désignation
- JLP
-
NCBI Accession
- NP_003962
-
UniProt
- O60271
-
Pathways
- Regulation of Muscle Cell Differentiation
Antigène
-